Text Only ::   Skip Nav ::

circare logo


Brochure Contact Home Privacy Site Map Terms of Use Tools Prev Next

print Print Page   ::   Link to CIRCARE Link To ::

Federal Regulations and Information on the Protection of Children in Research

2006-05-22: We've just begun organizing this information. We appreciate your patience.

OHRP Guidance and Information / Children in Research

OHRP Special Protections for Children as Research Subjects (Index). Available from http://www.hhs.gov/ohrp/children/

Protections for Children in Research: A Report to Congress in Accord with Section 1003 of P.L. 106-310, Children's Health Act of 2000. Office for Human Research Protections. May, 2001. Available from http://www.hhs.gov/ohrp/reports/ohrp502.pdf

Related:   Hearing on Protections for Foster Children Enrolled in Clinical Trials (Index). The Subcommittee on Human Resources of The Committee on Ways and Means, U.S. House of Representatives. 2005-05-18. Available from http://waysandmeans.house.gov/hearings.asp?formmode=detail&hearing=409&comm=2

Serial 109-8: Protections for Foster Children Enrolled in Clinical Trials. The Subcommittee on Human Resources of The Committee on Ways and Means, U.S. House of Representatives. 109th Congress / First Session. 2005-05-18. Available from http://waysandmeans.house.gov/hearings.asp?formmode=printfriendly&id=3055

HHS Survey of State Policies on the Participation of Foster Children in Clinical Trials. Available from http://waysandmeans.house.gov/media/pdf/welfare/062405hhssurvey.pdf. (Report courtesy of Senator Wally Herger.)

Children Involved as Subjects in Research: Guidance on the HHS 45 CFR 46.407 (407) Review Process. 2005-05-26. Available from http://www.hhs.gov/ohrp/children/Guidance_407Process.pdf.

Precursor Preference in Surfactant Synthesis of Newborns / Washington University Medical Center. 2005-01-13. Available from http://www.hhs.gov/ohrp/children/surfactant.html

Effects of a Single Dose of Dextroamphetamine in Attention Deficit Hyperactivity Disorder: A Functional Magnetic Resonance Study / National Institute of Mental Health. 2004-08-15. Available from http://www.hhs.gov/ohrp/children/adhd.html. (Withdrawn.)

Characterization of Mucus and Mucins in Bronchoalveolar Lavage Fluids from Infants with Cystic Fibrosis / University of North Carolina - Chapel Hill. 2004-05-14. Available from http://www.hhs.gov/ohrp/children/mucus.html

HIV replication and thymopoiesis in adolescents / University of California at Los Angeles (UCLA). 2004-03-05. Available from http://www.hhs.gov/ohrp/children/hiv.html

Sleep Mechanisms in Children: Role of Metabolism / Yeshiva University, Albert Einstein College of Medicine, Montefiore Medical Center. 2004-03-05. Available from http://www.hhs.gov/ohrp/children/sleep.html

Alcohol, sleep and circadian rhythms in young humans, study 2: Effects of evening ingestion of alcohol on sleep, circadian phase, and performance as a function of parental history of alcohol abuse/dependence / Rhode Island Hospital. 2003-12-09. Available from http://www.hhs.gov/ohrp/children/circadian.html

Precursors to Diabetes in Japanese American Youth / University of Washington and Children's Hospital and Regional Medical Center. 2003-05-27. Available from http://www.hhs.gov/ohrp/children/japanese.html

A multi-center, randomized dose-response study of the safety, clinical and immune responses of Dryvax administered to children 2 to 5 years of age / Harbor UCLA Medical Center. 2003-01-24. Available from http://www.hhs.gov/ohrp/children/dryvax.html

top

FDA Guidance and Information / Children in Research

FDA Pediatric Drug Development Page

Department of Health and Human Services, Food and Drug Adminstration Center for Drug Evaluation and Research. Pediatric Ethics Subcommittee. Meeting Transcript. 1999-04-23. Part 1 available from http://www.fda.gov/ohrms/dockets/ac/99/transcpt/3506t1a.pdf. Part 2 available from http://www.fda.gov/ohrms/dockets/ac/99/transcpt/3506t1b.pdf

Department of Health and Human Services, Food and Drug Adminstration Center for Drug Evaluation and Research. Pediatric Ethics Subcommittee. Slides. 1999-04-23. Available from http://www.fda.gov/ohrms/dockets/ac/99/slides/3506s1/index.htm;   http://www.fda.gov/ohrms/dockets/ac/99/slides/3506s2/index.htm;   http://www.fda.gov/ohrms/dockets/ac/99/slides/3506s3/index.htm;   http://www.fda.gov/ohrms/dockets/ac/99/slides/3506s4/index.htm;   http://www.fda.gov/ohrms/dockets/ac/99/slides/3506s5/index.htm;   http://www.fda.gov/ohrms/dockets/ac/99/slides/3506s6/index.htm

Department of Health and Human Services, Food and Drug Adminstration Center for Drug Evaluation and Research. Pediatric Ethics Subcommittee. Day 1: Ethical Issues. Meeting Transcript. 1999-11-15. Available from http://www.fda.gov/ohrms/dockets/ac/99/transcpt/3563t1.pdf

Department of Health and Human Services, Food and Drug Adminstration Center for Drug Evaluation and Research. Pediatric Ethics Subcommittee. Day 1: Ethical Issues. Slides. 1999-11-15. Available from http://www.fda.gov/ohrms/dockets/ac/99/slides/3563s1.htm

Department of Health and Human Services, Food and Drug Adminstration Center for Drug Evaluation and Research. Pediatric Ethics Subcommittee. Meeting Transcript. 2000-09-11. Available from http://www.fda.gov/ohrms/dockets/ac/00/transcripts/3641t1.pdf

Department of Health and Human Services, Food and Drug Adminstration Center for Drug Evaluation and Research. Pediatric Ethics Subcommittee. Briefing Information. 2000-09-11. Available from http://www.fda.gov/ohrms/dockets/ac/00/backgrd/3641b1.htm

Department of Health and Human Services, Food and Drug Adminstration Center for Drug Evaluation and Research. Pediatric Ethics Subcommittee. Slides. 2000-09-11. Available from http://www.fda.gov/ohrms/dockets/ac/00/slides/3641s1.htm

Department of Health and Human Services, Food and Drug Adminstration Center for Drug Evaluation and Research. Pediatric Ethics Subcommittee. Meeting Transcript. 2000-09-12. Available from http://www.fda.gov/ohrms/dockets/ac/00/transcripts/3642t1.pdf

Department of Health and Human Services, Food and Drug Adminstration Center for Drug Evaluation and Research. Pediatric Ethics Subcommittee. Briefing Information. 2000-09-12. Available from http://www.fda.gov/ohrms/dockets/ac/00/backgrd/3642b1.htm

Department of Health and Human Services, Food and Drug Adminstration Center for Drug Evaluation and Research. Pediatric Ethics Subcommittee. Meeting Transcript. 2001-04-23 and 24. Available from http://www.fda.gov/ohrms/dockets/ac/01/transcripts/3744t1.pdf

Department of Health and Human Services, Food and Drug Adminstration Center for Drug Evaluation and Research. Pediatric Ethics Subcommittee. Meeting Information and Transcripts. 2002-06-11. Available from http://www.fda.gov/ohrms/dockets/ac/cder02.htm#Anti-Infective

Department of Health and Human Services, Food and Drug Adminstration Center for Drug Evaluation and Research. Pediatric Ethics Subcommittee. Meeting Information and Transcripts. 2003-10-22 and 23. Available from http://www.fda.gov/ohrms/dockets/ac/cder03.html#Anti-Infective

Department of Health and Human Services, Food and Drug Adminstration Center for Drug Evaluation and Research. Pediatric Ethics Subcommittee. Meeting Index (2004 and 2005) Available from http://www.fda.gov/oc/opt/ethicsmeetings.html

Department of Health and Human Services, Food and Drug Adminstration Center for Drug Evaluation and Research. Pediatric Ethics Subcommittee. Meeting Index (1999-2004). Available from http://www.fda.gov/oc/opt/anti-infectivePAC.html

Department of Health and Human Services, Food and Drug Adminstration Center for Drug Evaluation and Research. Pediatric Advisory Committee. Meeting Index (2005). Available from http://www.fda.gov/oc/opt/PACmeetings.html

Department of Health and Human Services, Food and Drug Adminstration Center for Drug Evaluation and Research. Pediatric Advisory Committee. Meeting Index (2006). Available from http://www.fda.gov/ohrms/dockets/ac/oc06.htm#pac

Patient Access to New Therapeutic Agents for Pediatric Cancer / Report to Congress. 2003-12. Available from http://www.fda.gov/cder/pediatric/BPCA-ReportDec2003.doc

Pediatric Research Equity Act of 2003. 2003-12-03.   URL:   http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=108_cong_public_laws&docid=f:publ155.108

top

FDA Dockets

2006D-0172, OC 200690: Draft Guidance for Clinical Investigators, Institutional Review Boards, and Sponsors; Process for Handling Pediatric Referrals to the Food and Drug Administration: Additional Safeguards for Children in Clinical Investigations. Pages 27264-27266 [FR Doc. E6-07058 ] Available from http://www.fda.gov/OHRMS/DOCKETS/98fr/06d-0172-gdl0001.pdf


top

Last Updated: 2006-05-23

If you find the information on this page helpful please support CIRCARE with a tax-deductible contribution today. Because CIRCARE doesn't accept funds from pharmaceutical or medical device manufacturers, we depend on contributions from individuals like you to help us advocate for meaningful protection of human subjects in research. Donating on-line with PayPal is quick and easy. Find out more on our Support page.


All material on this site © CIRCARE Incorporated (2002- ) or as indicated. Single copies can be downloaded for personal education.   Adobe® Reader ::   ::

Valid HTML 4.01! Valid CSS!